Investment case
InspireMD Inc.
NSPR · 3 developments mapped · last assessed 2026-09-21
Market Ontology has mapped 3 macro, policy, and market developments to InspireMD Inc. since 2026-08-17. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for NSPR yet, so no modelled value is shown. The NSPR valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run NSPR on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
InspireMD, Inc. Initiates $9 Million Annualized Cost Savings Program
Direct cost reduction leading to improved profitability and cash flow.
· Moves future profitability growth, free cash flow generation
- Open question
InspireMD Announces Amendments to Series J and Series K Warrants for Potential $11 Million Proceeds
Direct capital raise, potential dilution, and financing certainty tied to product approval.
· Moves future cash flows (due to increased capital), dilution impact on per share metrics, probability of successful product launch
What changed, by assumption
- 2026-09-21InspireMD Announces Amendments to Series J and Series K Warrants for Potential $11 Million Proceeds
- 2026-09-21InspireMD Announces Amendments to Series J and Series K Warrants
- 2026-08-17InspireMD, Inc. Initiates $9 Million Annualized Cost Savings Program
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-09-21 | Net debt | Bearish | Liability-management transactions often reduce gross debt or push maturities out. | 0.70 |
| 2026-09-21 | Interest expense | Bearish | Tender/exchange extends maturity profile and typically lowers near-term interest expense. | 0.70 |
| 2026-07-02 | Share count | Bullish | Stock component of consideration dilutes existing acquirer holders. | 0.70 |
| 2026-07-02 | Net debt | Bullish | Cash component of consideration is typically debt-funded, raising net debt. | 0.70 |
| 2026-07-02 | Revenue | Bullish | Acquisition adds target revenue to acquirer P&L on close. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-21 | InspireMD Announces Amendments to Series J and Series K Warrants for Potential $11 Million Proceeds | mixed | 1-3m | 0.70 |
| 2026-09-21 | InspireMD Announces Amendments to Series J and Series K Warrants | mixed | 3-12m | 0.70 |
| 2026-08-17 | InspireMD, Inc. Initiates $9 Million Annualized Cost Savings Program | Bullish | 3-12m | 0.70 |